Related Articles
Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer
Clinical significance of LGR5 and CD44 expression in locally advanced rectal cancer after preoperative chemoradiotherapy
Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy
Clinical significance of radiation-induced CD133 expression in residual rectal cancer cells after chemoradiotherapy
Immunohistochemical features of CD133 expression: Association with resistance to chemoradiotherapy in rectal cancer